- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05492812
Sedation and Nursing Management in EEG Recording in Children
August 8, 2022 updated by: Serife Tutar, Suleyman Demirel University
Evaluation of the Effect of Chloral Hydrate, Hydroxyzine and Melatonin Used as Sedative Drugs in EEG Recording in Children
Electroencephalogram (EEG) has an important place in establishing the correct diagnosis, providing appropriate intervention, and predicting the prognosis in the long term in children.
When the literature is examined, it is seen that different sedative drugs (benzodiazepines, barbiturates, phenothiazine, chloral hydrate, hydroxyzine, melatonin, etc.) and their combinations are used to provide sedation during EEG recordings, but there is no ideal sedative drug.
Nurses working in the field of pediatric neurology in EEG recordings; It has important roles in preparing the child and parent for the procedure, applying sedation before the procedure, performing the EEG recording properly, monitoring vital signs during the procedure, monitoring the effects of the sedative substance after the procedure, and sending the patient home safely.
Pediatric nurses fulfill these roles by adopting a multidisciplinary team approach.
In this context, the aim of our research is; The aim of this study is to evaluate the effects of chloral hydrate, hydroxyzine and melatonin, which are used as sedative agents before EEG recording in children, on sleep success, time to fall asleep, side effects and EEG background.
Study Overview
Status
Completed
Detailed Description
The aim of this study is to evaluate the effects of chloral hydrate, hydroxyzine and melatonin, which are used as sedative agents before EEG recording in children, on sleep success, time to fall asleep, side effects and EEG background.It is a randomized controlled experimental study.The universe of the study consisted of all children who had EEG recordings in the Pediatric Neurology Outpatient Clinic of a tertiary hospital.
Its sample is; It comprised 180 children aged 1-7 years who met the inclusion criteria, evaluated for epilepsy, suspected epilepsy, febrile convulsions, and other neurological diseases.G power program was used to determine the sample size of the study.
For each group (chloral hydrate, hydroxyzine, melatonin and natural sleep) 45 individuals were included in the study by taking 95% power and 0.05 margin of error while making the calculation.
Randomization was carried out in the study in order to provide an equal number of samples for each group (chloral hydrate, hydroxyzine, melatonin and natural sleep) and to avoid bias.
"Block randomization method" was used in order to provide equal samples for all four groups in randomization.Data Collection tools of the research; Child's Information Form, Ramsay Sedation Score, Steward Recovery Score.
Statistical analyzes of the study were performed with the SPSS 20.0 (IBM Incorp, Chicago, IL, USA) program.
Descriptive measures were frequency (percentage ratio) for categorical variables, mean±SD and median for numerical variables; It was presented as Q1-Q3.
Conformity of continuous numerical measurements to normal distribution was tested by Kolmogorov-Smirnov method, but it was found that it did not fit normal distribution (p <0.05).
Multivariate logistic regression model was established to determine the properties that are effective on sedative substances.
A p value of <0.05 was considered statistically significant in the entire study.
In order to conduct the study, ethical approval from the Antalya Training and Research Hospital Clinical Research Ethics Committee, approval from the Turkish Medicines and Medical Devices Agency, institutional permission from the hospital where the study will be conducted, and written consent from the participants were obtained.
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Isparta, Turkey, 32000
- Suleyman Demirel University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 months to 5 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- According to the classification determined by the American Society of Anesthesiologist (ASA) (Dripps, 1963; Daabis, 2011), in the risk group of ASA I (normal healthy individual), ASA II (with mild systemic disease), the procedure preparation given by the EEG nurse is in accordance with the educational steps. The children who came to the shooting were included in the study.
Exclusion Criteria:
- Severe systemic disease (neurological, cardiac, respiratory, metabolic and gastrointestinal system), known hypersensitivity to the sedative agent, vomiting after sedative drug administration, waking up during the shooting, failing to fall asleep, and the procedure preparation training steps given by the EEG nurse Children who were not prepared properly were not included in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Chloral Hydrate
Chloral hydrate was administered orally to children at a dose of 25-50 mg/kg/dose.
After the sedative drug administration, the child was taken to a quiet and dark sleep room in the polyclinic environment with his parents in order to enable the child to fall asleep.
In this process, the child was evaluated by the nurse every 5 minutes with the Ramsay Sedation Score.
Children with a Ramsay Sedation Score of 4-6 were taken to the EEG room for recording.
During the sedation, the child's blood pressure, oxygen saturation and pulse were checked every 5 minutes.
EEG electrodes were placed in accordance with the international 10-20 electrode positioning system.
An average of 30 minutes of EEG recording was made for each patient.
The awakening process of children whose EEG recordings were completed was evaluated with the Steward Recovery Score.
Individuals with a score of 6 were accepted as awake, and the child's procedure was completed.
|
Evaluation of the effect of sedative agents applied during EEG recording in children
Chloral Hydrate
|
Experimental: Hydroxyzine
Hydroxyzine was administered orally to children at a dose of 1-2 mg/kg/dose.
After the sedative drug administration, the child was taken to a quiet and dark sleep room in the polyclinic environment with his parents in order to enable the child to fall asleep.
In this process, the child was evaluated by the nurse every 5 minutes with the Ramsay Sedation Score.
Children with a Ramsay Sedation Score of 4-6 were taken to the EEG room for recording.
During the sedation, the child's blood pressure, oxygen saturation and pulse were checked every 5 minutes.
EEG electrodes were placed in accordance with the international 10-20 electrode positioning system.
An average of 30 minutes of EEG recording was made for each patient.
The awakening process of children whose EEG recordings were completed was evaluated with the Steward Recovery Score.
Individuals with a score of 6 were accepted as awake, and the child's procedure was completed.
|
Evaluation of the effect of sedative agents applied during EEG recording in children
Hydroxyzine
|
Experimental: Melatonin
Melatonin was administered orally 3 mg up to 15 kilograms, and 6 mg after 15 kilograms.After the sedative drug administration, the child was taken to a quiet and dark sleep room in the polyclinic environment with his parents in order to enable the child to fall asleep.
In this process, the child was evaluated by the nurse every 5 minutes with the Ramsay Sedation Score.
Children with a Ramsay Sedation Score of 4-6 were taken to the EEG room for recording.
During the sedation, the child's blood pressure, oxygen saturation and pulse were checked every 5 minutes.
EEG electrodes were placed in accordance with the international 10-20 electrode positioning system.
An average of 30 minutes of EEG recording was made for each patient.
The awakening process of children whose EEG recordings were completed was evaluated with the Steward Recovery Score.
Individuals with a score of 6 were accepted as awake, and the child's procedure was completed.
|
Evaluation of the effect of sedative agents applied during EEG recording in children
Melatonin
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success in falling asleep
Time Frame: 12 month
|
After the sedative drug administration, the child was taken to a quiet and dark sleep room in the polyclinic environment with his parents in order to enable the child to fall asleep.
In this process, the child was evaluated by the nurse every 5 minutes with the Ramsay Sedation Score.
Children with a Ramsay Sedation Score of 4-6 were taken to the electroencephalogram room for recording.
|
12 month
|
Sleep Time
Time Frame: 12 month
|
After the sedative drug administration, the child was taken to a quiet and dark sleep room in the polyclinic environment with his parents in order to enable the child to fall asleep.
In this process, the child was evaluated by the nurse every 5 minutes with the Ramsay Sedation Score.
Children with a Ramsay Sedation Score of 4-6 were taken to the electroencephalogram room for recording.The time elapsed during this period was recorded as the time to fall asleep.
|
12 month
|
Ramsay Sedation Score on electroencephalogram background
Time Frame: 12 month
|
After the sedative drug administration, the child was taken to a quiet and dark sleep room in the polyclinic environment with his parents in order to enable the child to fall asleep.
In this process, the child was evaluated with the Ramsay Sedation Score.
Children with a Ramsay Sedation Score of 4-6 were taken to the electroencephalogram room for recording.
Electroencephalogram electrodes were placed in accordance with the international 10-20 electrode positioning system.
An average of 30 minutes of electroencephalogram recording was made for each patient.
Post-extraction records were evaluated by a pediatric neurologist and recorded in the data collection form.
|
12 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Şerife Tutar, Suleyman Demirel University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
December 31, 2021
Study Registration Dates
First Submitted
July 15, 2022
First Submitted That Met QC Criteria
August 8, 2022
First Posted (Actual)
August 9, 2022
Study Record Updates
Last Update Posted (Actual)
August 9, 2022
Last Update Submitted That Met QC Criteria
August 8, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Nervous System Diseases
- Dyssomnias
- Sleep Wake Disorders
- Neurologic Manifestations
- Sleep Deprivation
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Protective Agents
- Dermatologic Agents
- Hypnotics and Sedatives
- Antioxidants
- Histamine H1 Antagonists
- Histamine Antagonists
- Histamine Agents
- Antipruritics
- Melatonin
- Hydroxyzine
- Chloral Hydrate
Other Study ID Numbers
- 2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
Will be shared after the research is published
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Deprivation
-
University of PennsylvaniaCompletedSleep Restriction Then Total Sleep Deprivation | Total Sleep Deprivation Then Sleep RestrictionUnited States
-
Herlev HospitalTRYG Foundation; Danish Medical AssociationCompletedEffect of Sleep DeprivationDenmark
-
Christian BaumannCompletedAcute and Partial Sleep DeprivationSwitzerland
-
Dr. Osman HospitalCairo UniversityUnknownEffect of Insomnia and Sleep Deprivation in 3rdtrimesterEgypt
-
Hallym University Medical CenterCompletedWe Investigated the Effect of Sleep Deprivation on the Tear Film and Ocular Surface.Korea, Republic of
-
University of PittsburghNational Institute of Mental Health (NIMH)Not yet recruitingSleep | Sleep Disturbance | Insufficient SleepUnited States
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSleep | Sleep Disturbance | Sleep DeprivationUnited States
-
University of ChicagoCompleted
-
Beth Israel Deaconess Medical CenterNational Institute of Mental Health (NIMH)Active, not recruiting
Clinical Trials on Sedation and Nursing Management in EEG Recording in Children
-
Hospices Civils de LyonRecruitingPersistent Vegetative StateFrance
-
Institut National de la Santé Et de la Recherche...UnknownAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Karl Landsteiner Institute for Clinical Epilepsy...AIT Austrian Institute of Technology GmbH; Brainhero GmbHRecruiting
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and PreventionCompletedHand, Foot and Mouth DiseaseChina
-
University of Missouri-ColumbiaUnited States Department of DefenseRecruitingAutism Spectrum Disorder | Insomnia ChronicUnited States
-
Children's Hospital of PhiladelphiaTerminatedRespiratory Failure | HypotensionUnited States
-
Sisters of Mercy University HospitalBioGaia ABUnknownLactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in ChildrenAbdominal Pain | Constipation - FunctionalCroatia
-
Wake Forest University Health SciencesCompletedObesity, ChildhoodUnited States
-
Boston UniversityNational Institute on Aging (NIA)WithdrawnAlzheimer Disease | Mild Cognitive Impairment | Dementia, Mild
-
Marmara UniversityCompletedQuality of Life | Pain | Balance; Distorted | Aging ProblemsTurkey